Search Results
Oct 21, 2025, 07:00 ET Above and Beyond Celebrates 10 Years of Redefining Recovery with Milestone Gala Event
https://e.givesmart.com/events/GP3/
More news about: Above and Beyond Family Recovery
Oct 20, 2025, 06:00 ET GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
cancer control. Lancet Oncol. 2015;16(12):1231-1272. doi:10.1016/S1470-2045(15)00205-3 Koo MM, Hamilton W, Walter FM, Rubin GP, Lyratzopoulos G. Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence. Neoplasia. 2018;20(2):165-174. doi:10.1016/j.neo.2017.11.005
More news about: GRAIL, Inc.
Oct 19, 2025, 03:00 ET Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
inhibitor). The linker is designed to complement the exatecan payload, enabling a stable and homogenous ADC. The payload is a weak substrate for BCRP/P-gp, which are drug efflux pumps that drive chemoresistance to many therapies. In preclinical data, this linker-payload has been shown to have an increased
More news about: Multitude Therapeutics, Inc.
Oct 18, 2025, 10:30 ET PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
INTERACTIONS Effects of other drugs on PADCEV (Dual P-gp and Strong CYP3A4 Inhibitors)Concomitant use with dual P-gp and strong CYP3A4 inhibitors may increase unconjugated monomethyl auristatin E exposure, which may increase the incidence
More news about: Astellas Pharma Inc.
Oct 17, 2025, 12:04 ET Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave
Important Information Two Seas, Two Seas Capital GP LLC ("Two Seas GP"), and Sina Toussi ("Mr. Toussi" and, together with Two Seas and Two Seas GP, the "Participants") have filed a definitive proxy statement and GOLD proxy card (the "Proxy Statement")
More news about: Two Seas Capital
Oct 16, 2025, 08:00 ET Blue Owl Capital Hires Greg Porteous to Lead Defined Contribution Retirement Solutions
With over $284 billion in assets under management as of June 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Blue Owl Capital
Oct 15, 2025, 10:30 ET Corporate Training Market to Reach $805.6 billion, Globally, by 2035 at 7.0% CAGR: Allied Market Research
Leading Market Players: - Bizlibrary GP Strategies Corporation Franklin Covey Co. City & Guilds Group D2L
More news about: Allied Market Research
Oct 15, 2025, 08:00 ET S&P Global Agrees to Acquire With Intelligence from Motive Partners for $1.8 Billion, Establishing Its Leadership in Private Markets Intelligence
S&P Global as a global leader in private markets data and solutions. It will bring to the market With Intelligence's proprietary fund data and LP/GP relationship intelligence complemented by S&P Global's private company and transaction data for the Front Office. In the Middle Office, customers
More news about: S&P Global
Oct 15, 2025, 01:30 ET NuSummit Strengthens its Data and AI Capabilities with Origamis AI Platform Integration
Investcorp is a global investment manager, specializing in alternative investments across private equity, real estate, credit, absolute return strategies, GP stakes, infrastructure, and insurance asset management. Since our inception in 1982, we have focused on generating attractive returns for our clients
More news about: NuSummit
Oct 14, 2025, 12:21 ET Natural Field entwickelt die Co-Loading-Liposomen-Technologie weiter, um die Wirksamkeit bei der Gesundheitsförderung zu steigern
Gewöhnliche Liposomen sind nach wie vor auf die zelluläre Aufnahme nach der extrazellulären Freisetzung angewiesen, die leicht durch den P-Glykoprotein (P-gp)-Efflux begrenzt wird, was zu einer unzureichenden intrazellulären Eintrittseffizienz führt. Die neue Co-Loading-Liposomen-Technologie kann diesen Effluxweg
More news about: Natural Field
Oct 14, 2025, 12:19 ET Natural Field progresse dans la technologie de cochargement des liposomes pour renforcer l'efficacité du soutien médical
dépendent toujours de l'absorption cellulaire après leur libération extracellulaire, qui est facilement limitée par l'efflux de la glycoprotéine P (P-gp). Cela se traduit par une efficacité insuffisante de l'entrée intracellulaire. La nouvelle technologie de cochargement des liposomes contourne non seulement
More news about: Natural Field
Oct 14, 2025, 12:13 ET Natural Field avanza en la tecnología de co-carga de liposomas para aumentar la eficacia del apoyo a la salud
convencionales aún dependen de la captación celular tras la liberación extracelular, la cual se ve fácilmente limitada por el eflujo de la glicoproteína P (P-gp), lo que resulta en una eficiencia de entrada intracelular insuficiente. La nueva tecnología de co-carga de liposomas no solo puede evitar eficazmente
More news about: Natural Field
Oct 14, 2025, 11:00 ET GP PRO Unveils Hand Hygiene Healthcare Survey Results, Revealing Nursing Practices and Priorities to Elevate Infection Prevention and Control
(HAIs)," said Ashley Butler, vice president and general manager, Skin Care, Tissue, and Wiper, GP PRO. "Our survey findings are invaluable in continuing to build empathy within our organization while helping inform GP PRO's continued development of user-friendly, touchless dispensers, as well as highly innovative
More news about: Georgia-Pacific
Oct 13, 2025, 11:00 ET Natural Field Drives Breakthroughs in Co-loading Liposome Technology, Accelerating Upgrading of Raw Materials for Cardiovascular and Gut Health
Improved Stability: Ordinary liposomes still rely on cellular uptake after extracellular release, which is easily limited by P-glycoprotein (P-gp) efflux, resulting in insufficient intracellular entry efficiency. The new co-loading liposome technology can not only effectively bypass this efflux
More news about: Natural Field
Oct 13, 2025, 09:00 ET Two Seas Capital Publishes Investor Presentation Describing Why It Opposes Core Scientific's Proposed Sale to CoreWeave
Important Information Two Seas, Two Seas Capital GP LLC ("Two Seas GP"), and Sina Toussi ("Mr. Toussi" and, together with Two Seas and Two Seas GP, the "Participants") have filed a definitive proxy statement and GOLD proxy card (the "Proxy Statement")
More news about: Two Seas Capital
Oct 13, 2025, 06:45 ET Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
avoided, increase the dosage of Inluriyo. Imlunestrant inhibits both P-gp and BCRP. Avoid concomitant use unless otherwise recommended in the Prescribing Information for P-gp or BCRP substrates where minimal concentration changes may lead to serious adverse reactions.
More news about: Eli Lilly and Company
Oct 13, 2025, 04:00 ET Natural Field Advances Co-loading Liposome Technology to Boost Health Support Efficacy
2.Improved Stability: Ordinary liposomes still rely on cellular uptake after extracellular release, which is easily limited by P-glycoprotein (P-gp) efflux, resulting in insufficient intracellular entry efficiency. The new co-loading liposome technology can not only effectively bypass this efflux
More news about: Natural Field
Oct 10, 2025, 18:42 ET 健康管理の主導権は自分にある？アジアのトップ医療専門家が「イエス」と回答、その理由と方法を明かす
Organization（WHO）によって認められているセルフケアは、個人が健康を維持し、病気を予防し、責任を持って状態を管理する力を与え、コミュニティと医療システムの両方を強化します。 APSMI 会長、GP Farmasi 代表、PT Konimex CEOのRachmadi Joesoef氏は、「このサミットは責任あるセルフケアを推進する上で新たなマイルストーンとなり、規制当局、業界、医療専門家を集めて協力関係を成果につなげるものだ」と語りました。
More news about: Asia Pacific Self-Medication Industry
Oct 10, 2025, 09:37 ET 健康触手可及？亚洲顶尖医疗专家给出肯定答案并揭示实现路径
本届峰会以"自我保健：从共同愿景到协同行动"为主题，强调亚太地区需要将共识转化为基于实证的具体行动。世界卫生组织指出，自我保健能帮助人们维护健康、预防疾病并负责任地进行自我管理，从而增强社区韧性和完善医疗体系。 APSMI主席、GP Farmasi代表及PT Konimex首席执行官Rachmadi Joesoef表示，本次峰会汇聚监管机构、行业代表与医疗专家，旨在将合作转化为实际影响力，标志着推动负责任自我保健的又一里程碑。 在2024年发布的《曼谷自我保健医疗产品联合倡议》（Bangkok
More news about: Asia Pacific Self-Medication Industry
Oct 09, 2025, 08:00 ET Blue Owl Capital Launches TALON: A Tax Education Platform Empowering Financial Advisors in Private Markets
With over $284 billion in assets under management as of June 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Blue Owl Capital
Oct 09, 2025, 01:01 ET Parkland Corporation anuncia la fecha límite de las elecciones para el Acuerdo de Sunoco
acuerdo (conforme a las enmiendas de un contrato de enmienda del 26 de mayo de 2025) con Sunoco LP (NYSE:SUN) ("Sunoco"), SunocoCorp LLC (antes NuStar GP Holdings LLC), y 2709716 Alberta ULC (antes 2709716 Alberta Ltd.) (el "Comprador"), conforme a lo cual Sunoco, mediante el Comprador, comprará todas
More news about: Parkland Corporation
Oct 09, 2025, 00:59 ET Parkland Corporation anuncia la fecha límite de las elecciones para el Acuerdo de Sunoco
acuerdo (conforme a las enmiendas de un contrato de enmienda del 26 de mayo de 2025) con Sunoco LP (NYSE:SUN) ("Sunoco"), SunocoCorp LLC (antes NuStar GP Holdings LLC), y 2709716 Alberta ULC (antes 2709716 Alberta Ltd.) (el "Comprador"), conforme a lo cual Sunoco, mediante el Comprador, comprará todas
More news about: Parkland Corporation
Oct 08, 2025, 10:10 ET NATIONAL ECZEMA ASSOCIATION LAUNCHES ECZEMA AWARENESS MONTH WITH CAPITOL HILL POLICY SUMMIT, PUBLIC EDUCATION, AND COMMUNITY EVENTS
NationalEczema.org. References 1. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73.
More news about: National Eczema Association
Oct 08, 2025, 08:00 ET Cari Lodge, Veteran in the Secondaries Market, Launches a New Secondaries Firm, Aqualis Partners
plan to focus on purchasing small LP interests, primarily in the U.S. and Europe, and complement this core focus with opportunistic investments in GP-leds, directs, preferreds, seasoned primaries, as well as investments in other geographies. We will combine decades of experience in the secondaries market
More news about: Aqualis Partners
Oct 08, 2025, 07:55 ET Parkland Corporation Announces Election Deadline for the Sunoco Arrangement
arrangement agreement (as amended by an amending agreement dated May 26, 2025) with Sunoco LP (NYSE:SUN) ("Sunoco"), SunocoCorp LLC (formerly, NuStar GP Holdings LLC), and 2709716 Alberta ULC (formerly, 2709716 Alberta Ltd.) (the "Purchaser"), pursuant to which Sunoco, through the Purchaser, will acquire
More news about: Parkland Corporation